Effect of dalteparin administration on thrombin generation kinetics in healthy dogs

Pharmacokinetics of Subcutaneous Low Molecular Weight Heparin (Enoxaparin) in Dogs

(2014) Kari V. Lunsford et al.   JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION

Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: a rebuttal

(2013) H. C. Hemker et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Viscoelastic pharmacodynamics after dalteparin administration to healthy dogs

(2012) Benjamin M. Brainard et al.   AMERICAN JOURNAL OF VETERINARY RESEARCH

Thrombin generation: What have we learned?

(2012) Raed Al Dieri et al.   BLOOD REVIEWS

Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism

(2012) Y. BUYUE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Diseases Associated with Thrombosis

(2012) Armelle de Laforcade   Topics in Companion Animal Medicine

Antithrombotic Therapy

(2012) Stephanie Ann Smith   Topics in Companion Animal Medicine

Monitoring unfractionated heparin therapy in dogs by measuring thrombin generation

(2011) Virginie Allegret et al.   VETERINARY CLINICAL PATHOLOGY

The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation

(2010) Laura Green et al.   BRITISH JOURNAL OF HAEMATOLOGY

Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: A randomised controlled trial in healthy elderly adults

(2010) Meyer M. Samama et al.   THROMBOSIS RESEARCH

Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters

(2008) Joost J van Veen et al.   BLOOD COAGULATION & FIBRINOLYSIS

In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time

(2008) Lisbeth R. Jessen et al.   VETERINARY CLINICAL PATHOLOGY